^
Association details:
Biomarker:GNG4 overexpression
Cancer:Bladder Cancer
Drug Class:Immunotherapy
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
Title:

G-Protein Subunit Gamma 4 as a Potential Biomarker for Predicting the Response of Chemotherapy and Immunotherapy in Bladder Cancer

Published date:
04/14/2022
Excerpt:
The associations between GNG4 expression and survival in BLCA patients under or not under immunotherapy were evaluated using seven BLCA cohorts….The high-GNG4-expression group displayed a better response to immunotherapy...
DOI:
10.3390/genes13040693